Delayed acyclovir therapy in neonates with herpes simplex virus infection is associated with an increased odds of death compared with early therapy
Evidence Based Medicine · 2013
DOI: 10.1136/eb-2012-100674 ↗Kurz gefasst
Kommentar in der Zeitschrift Evidence Based Medicine, 2013. Verfasst von Sarah S Long. Beteiligte Einrichtung: Section of Infectious Diseases, St Christopher's Hospital for Children, Philadelphia, PA 19134, USA. sarah.long@drexelmed.edu. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Section of Infectious Diseases, St Christopher's Hospital for Children, Philadelphia, PA 19134, USA. sarah.long@drexelmed.edu
Zitieren
APA
Long, S. S. (2013). Delayed acyclovir therapy in neonates with herpes simplex virus infection is associated with an increased odds of death compared with early therapy. Evidence Based Medicine. https://doi.org/10.1136/eb-2012-100674
Vancouver
Long SS. Delayed acyclovir therapy in neonates with herpes simplex virus infection is associated with an increased odds of death compared with early therapy. Evidence Based Medicine. 2013. doi:10.1136/eb-2012-100674
BibTeX
@article{Long2013,
author = {Long, Sarah S},
title = {Delayed acyclovir therapy in neonates with herpes simplex virus infection is associated with an increased odds of death compared with early therapy},
journal = {Evidence Based Medicine},
year = {2013},
doi = {10.1136/eb-2012-100674}
}
EUVIMED